Galaxy Surfactants Ltd (NSE:GALAXYSURF)
₹ 2,333 +14.8 (+0.64%) Market Cap: 82.78 Bil Enterprise Value: 77.67 Bil PE Ratio: 23.45 PB Ratio: 3.02 GF Score: 90/100

Q1 2027 Galaxy Surfactants Ltd Earnings Call Transcript

Aug 14, 2026 / 06:30AM GMT
Release Date Price: ₹2508.4 (+20.00%)

Key Points

Positve
  • Galaxy Surfactants Ltd (NSE:GALAXYSURF) reported its highest-ever quarterly EBITDA of INR252.5 crores, nearly doubling profitability year-over-year.
  • Consolidated volumes grew 5% year-on-year, with India growing 11% and the Rest of the World region growing 6%, led by strong demand recovery in the Americas and double-digit growth in APAC.
  • EBITDA per metric ton improved significantly to INR35,458 from INR20,009 in the prior year, driven by a healthier product mix, recovery in customer demand, and disciplined commercial execution.
  • The company raised its full-year EBITDA per metric ton guidance to INR24,000-25,000 from INR19,000-21,000, reflecting confidence in sustained structural improvements.
  • Innovation momentum continues with new product launches like SimpliX and Galaxy HerthBioserv, which are gaining customer acceptance and contributing to growth in the premium specialty portfolio.
  • The EPC project in Mexico is progressing as planned, with commercialization expected within the next 12 months, providing additional income streams.
  • The company has successfully navigated geopolitical disruptions, particularly in the AMET region, showing resilience and recovering volumes sequentially by 19%.
Negative
  • The operating environment remains volatile, with feedstock prices (both petrochemical and oleochemical) experiencing sharp fluctuations due to geopolitical developments in West Asia, posing ongoing risks to supply chains and costs.
  • AMET region volumes declined 4% year-on-year due to supply chain disruptions in Egypt, and the region remains exposed to geopolitical uncertainties that could impact future performance.
  • The exceptional EBITDA per metric ton of INR35,458 is not expected to be sustained, with management guiding for a normalized range of INR21,000-22,000 per metric ton for the remaining quarters.
  • Potential risks from the Indonesian biodiesel mandate (B40 to B50) could keep palm oil and fatty alcohol prices elevated, impacting input costs and margins.
  • Customer restocking due to supply chain fears may have inflated Q1 volumes, and there is uncertainty about whether demand momentum will continue, especially with potential monsoon deficits affecting rural demand in India.
  • The company faces ongoing challenges from elevated freight costs, port congestion, and longer transit times, which could pressure margins.
  • The competitive landscape is evolving, with a major competitor (BASF) announcing plant closures, but the company has not yet quantified the potential demand upside or market share gains.
Operator

Ladies and gentlemen, good day, and welcome to Galaxy Surfactants Limited Q1 FY27 earnings conference call. (Operator Instructions)

Please note, this conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. I now hand the conference over to Mr. K. Natarajan, Managing Director, Galaxy Surfactants Limited. Thank you, and over to you, sir.

Natarajan Krishnan
Galaxy Surfactants Ltd - Managing Director, Chief Executive Officer

Thank you. A very good afternoon, ladies and gentlemen. It gives me immense pleasure to welcome you all to our Q1 '26, '27 conference call. There is a saying that smooth seeds do not make skilled sailors. Over the last two years, our company has navigated some exceptionally turbulent waters, geopolitical uncertainty, supply chain disruptions, reformulations and unprecedented volatility across

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot